Search Our Site

FDA Approves Procysbi

FDA Approves Procysbi

FDA Approves Procysbi For Rare Genetic Disorder In April 2013, Procysbi was FDA approved as an orphan drug for the treatment of nephropathic cystinosis.  Cystinosis affects only roughly 500 patients in the United States. The disorder causes the amino acid cystine to accumulate in every cell of the body, leading to kidney problems and the... Read More »

Read More →

FDA Approves Procysbi For Rare Genetic Disorder In April 2013, Procysbi was FDA approved as an orphan drug for the treatment of nephropathic cystinosis.  Cystinosis affects only roughly 500 patients in the United States. The disorder causes the amino acid cystine to accumulate in every cell of the body, leading to kidney problems and the… Read More »

[...]

Read More

LYNNFIELD-BASED MEDICAL CLAIMS AND CONSULTING FIRM HIRES NATIONAL SALES DIRECTOR IN RESPONSE TO LARGESCALE NEW PRODUCT LAUNCH.     October 1, 2013 – Lynnfield, MA – Advanced Medical Strategies, a physician-led medical claims and consulting firm in Lynnfield, has hired a national sales director in response to continued growth and a large-scale new product launch…. Read More »

[...]

Read More

Page 49 of 49

Categories
Archives